Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Eupraxia Pharmaceuticals Inc.
Market Cap
$258.80M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$256.77M
EBITDA Margin
-9077.06%
TTM Avg
-6066.11%
3Y Avg
-4339.03%
5Y Avg
-4339.03%
Market Cap
$258.85M
EBITDA Margin
-243.80%
TTM Avg
-818.13%
3Y Avg
-818.13%
5Y Avg
-1197.02%
Market Cap
$261.24M
EBITDA Margin
-5226.40%
TTM Avg
-5226.40%
3Y Avg
-5226.40%
5Y Avg
-21156.92%
Market Cap
$261.28M
EBITDA Margin
-50.56%
TTM Avg
-27.90%
3Y Avg
-8.82%
5Y Avg
-5.54%
Market Cap
$261.17M
EBITDA Margin
-768.62%
TTM Avg
-551.06%
3Y Avg
-374.75%
5Y Avg
-290.29%
Market Cap
$256.98M
EBITDA Margin
-1857.26%
TTM Avg
-1020.57%
3Y Avg
-1032.24%
5Y Avg
-903.20%
Market Cap
$256.57M
EBITDA Margin
-4.72%
TTM Avg
-1.10%
3Y Avg
6.56%
5Y Avg
4.38%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eupraxia Pharmaceuticals Inc. (EPRX) | $258.80M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $256.77M | -9077.06% | -6066.11% | -4339.03% | -4339.03% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $258.85M | -243.80% | -818.13% | -818.13% | -1197.02% |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | -5226.40% | -5226.40% | -5226.40% | -21156.92% |
| OraSure Technologies, Inc. (OSUR)vs › | $261.28M | -50.56% | -27.90% | -8.82% | -5.54% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $261.17M | -768.62% | -551.06% | -374.75% | -290.29% |
| AC Immune S.A. (ACIU)vs › | $256.98M | -1857.26% | -1020.57% | -1032.24% | -903.20% |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.57M | -4.72% | -1.10% | 6.56% | 4.38% |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $264.68M | -20.52% | -21.55% | -22.69% | -17.32% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
